KMTS

NASDAQStock

KESTRA MEDICAL TECHNOLOGIES, LTD.

$17.91-1.11 (-5.84%)

52-Week Range

$14.46
$28.01

Key Stats

Market Cap

1.0B

P/E Ratio

Dividend Yield

Beta

0.17

Volume

545.0K

Avg Volume

321.4K

Performance

1M

-29.35%

3M

-28.17%

6M

-18.02%

YTD

-22.02%

1Y

-23.24%

3Y

-12.91%

5Y

-12.91%

Price Chart

ETF Exposure

KMTS is held by 63 ETFs

ETFFund NameWeight
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 2

About KMTS ETF Exposure

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.0B, KMTS is a widely held institutional stock. The stock currently trades at $17.91. Investors can gain exposure to KMTS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold KMTS, sorted by portfolio weight.